A new randomized placebo-controlled trial found vaporized THC-plus-CBD cannabis improved acute migraine symptoms compared with placebo. The study represents one of the strongest migraine cannabis trials published to date. Dr. Caplan explains why formulation details and cannabinoid ratios matter clinically.
UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Migraine.
Migraine is a primary headache disorder, which leads to diminished health-related quality of life (HRQoL). There is limited evidence assessing efficacy of ca…
Is there a place for cannabis in your migraine toolkit? A recent study found that a … – Instagram
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic MigrainePain ManagementEvidence QualityHeadacheResearch Methods Why This MattersMigraine affects over 1 billion people globally...
Are medical cannabis patients finally finding lasting relief from migraines? New research shows …
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic MigrainePain ManagementNeurologyEvidence QualityPatient Monitoring Why This MattersMigraine affects over 1 billion people globally and...
Medical Cannabis Can Provide Sustained Relief for Migraines – NORML
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic MigrainePain ManagementPreventive TherapyChronic ConditionsLongitudinal Data Why This MattersMigraine affects 12% of the population with...
Cannabis for Migraine Headache with Nat Schuster, MD – YouTube
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic MigraineHeadachePain ManagementNeurologyEvidence Gaps Why This MattersMigraine affects over 1 billion people globally and remains...
The First Randomized Trial Of Cannabis For Migraine Relief – And What It Found
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic MigraineHeadachePain ManagementClinical TrialsNeurology Why This MattersThis represents the first randomized controlled trial specifically...
Endocannabinoid Modulation in Headache: Mechanisms, Models, and Translational Therapies.
Headache disorders, including migraine, tension-type headache, trigeminal autonomic cephalalgias, post-traumatic headache and medication overuse headache, re…
Research Digest: 20 Recent Studies – March 19, 2026
CED Clinical Relevance #85 Research Authority Peer-reviewed research curated for clinical relevance and evidence quality. Recent research digest. 20 of 20 most recent studies from our monitored feeds. CED Clinical Relevance #81...